W. He

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.

D. Clemmons, B. Gertz, M. Murphy, 1998, The Journal of clinical endocrinology and metabolism.

Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Osteoporosis and Atherosclerosis

W. Niu, Chao Ma, Chi Zhou, 2022, Frontiers in Endocrinology.

Inverse association between low-density lipoprotein cholesterol and bone mineral density in young- and middle-aged people: The NHANES 2011–2018

Weihua Fang, Tianye Lin, Fangjun Xiao, 2022, Frontiers in Medicine.

Effects of sodium‐glucose cotransporter‐2 inhibitors and aldosterone antagonists, in addition to renin‐angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta‐analysis

Lu Zhao, W. He, Shuo Yang, 2022, Diabetes, obesity & metabolism.

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.

R. Evans, J. Olefsky, Y. Barak, 2000, The Journal of clinical investigation.

The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis

Wei He, Lu Zhao, W. He, 2022, Drugs.

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis

Lu Zhao, W. He, Shuo Yang, 2022, PloS one.

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.

D. Clemmons, B. Gertz, M. Murphy, 1998, The Journal of clinical endocrinology and metabolism.